| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $4.95B | $4.57B | $4.25B |
| YoY Revenue Growth % | +8.3% | +7.5% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.13B | $893.5M | $547.4M |
| Operating Margin % | 22.8% | 19.5% | 12.9% |
| Net Income (GAAP) | $875.0M | $936.9M | $1.37B |
| EBITDA (Normalized) | $1.15B | $914.8M | $700.5M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.60B | $1.29B | $1.05B |
| Capital Expenditures (CapEx) | $23.9M | $26.6M | $191.4M |
| Free Cash Flow (FCF) | $1.58B | $1.26B | $856.2M |
| FCF Margin % | 31.8% | 27.6% | 20.1% |
| Return on Invested Capital (ROIC %) | 28.8% | 19.8% | 9.7% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $3.77B | $3.78B | $1.73B |
| Total Stockholders' Equity | $215.1M | $692.1M | $3.54B |